The International Consortium on Meningiomas (ICOM) – Tuesday, May 21, 2024
March 21, 2024
ICOM – Tues May 21The International Consortium on Meningiomas (ICOM) is hosting a scientific day on Tuesday, May 21 as part of University of Toronto Division of Neurosurgery 100 Years and CNSF 2024 Congress.
Led by Dr. Gelareh Zadeh, this consortium was formed to increase awareness for this understudied disease and conduct cutting-edge meningioma research through international and multidisciplinary collaboration. This meeting’s program will feature updates on ongoing collaborative research as well as a practical overview of modern meningioma management, with themes including surgical management, biomarkers, clinical trials updates and more. We will also host a molecular tumour board where complex cases are reviewed by an expert multidisciplinary panel with opportunity for audience involvement. These sessions will be highly relevant to anyone involved in meningioma research or clinical care and all are welcome to attend.
Register for course HERE
Submit an Abstract HERE
ICOM Agenda
Moderators: Michael Cusimano, Justin Wang
8:00 – 8:05 Overview of ICOM: Meningioma Consortium and 100th Anniversary of Neurosurgery
Gelareh Zadeh
8:05 – 8:20 Sex and Racial Disparities in Meningioma
Quinn T. Ostrom
8:20 – 8:35 Tumour Microenvironment of Meningioma
Christel Herold-Mende
8:35 – 8:50 Epigenomic drivers of Meningioma
Mark Youngblood
8:50 – 9:05 Metabolic Landscape of Aggressive Meningioma
Alex Landry
9:05 – 9:20 Discussion/Break
9:20 – 9:35 Predictive Signatures for Meningiomas
Akash J. Patel
9:35 – 9:50 Role of Radiotherapy for Meningioma
Justin Wang
9:50 – 10:05 Biomarkers of Radiation Response
David R. Raleigh
10:05 – 10:20 Role of Liquid Biopsy
Houtan Noushmehr
10:20 – 10:35 Update on EANO Guidelines for Molecular Testing, Biomarker Consortium
Susan Short
10:35 – 10:50 Discussion/Break
10:50 – 11:00 Health-related Quality of Life in Meningioma
Tobias Walbert
11:00 – 11:15 Development and Validation of a Quality of Life Questionnaire for Meningioma
Michael Cusimano
11:15 – 11:30 Neurocognitive, Psychological, and Functional Outcomes in Patients with Meningioma
Angela Sekely
11:30 – 11:45 International Tuberculum Sellae Meningioma Study
Michael W. McDermott
11:45 – 12:00 Role of Preoperative Embolization
Vitor Mendes Pereira
12:00 – 12:15 Endoscopic Anatomy From an ENT Perspective
Ian Witterick
12:15 – 1:00 Lunch
Moderators: Farshad Nassiri, Susan Short
1:00 – 2:00 Molecular Tumour Board
Speaker: Michael Cusimano, Kate Drummond, Evanthia Galanis, Andrew Gao, Jorge-Christian Tonn, Derek Tsang
2:00 – 2:15 DOTATATE- PET and Theranostics of Meningioma: European Update
Joerg-Christian Tonn
2:15 – 2:30 Clinical Trial Design of Theranostics of Meningioma – North American Update
Erik P. Sulman
2:30 – 2:45 Alliance Trials and Opportunities: The Role of Umbrella Trials in Meningioma
Evanthia Galanis
2:45 – 3:00 Radiation versus Observation for Atypical Meningioma: update from the ROAM/EORTC1308 trial
Michael D. Jenkinson
3:00 – 3:15 Evaluating Immunohistochemical Surrogates for Meningioma Molecular Subtypes
P.J. Cimino
3:15 – 3:30 Outcomes in Grade 3 Meniningioma
Alexander Rebchuk
3:30 – 3:45 Updates on Molecular Pathology of Meningioma/WHO grading
Stephen Yip
3:45 – 4:00 Mutation Landscape of Meningioma Grade Progression
Kate Drummond
4:00 – 4:15 cIMPACT update
Felix Sahm
4:15 Discussion/ Closing Remarks
Speaker: Gelareh Zadeh
